Literature DB >> 6329964

Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study.

Y Maeda, M Furukawa, Y Takehara, K Yoshimura, K Miyamoto, T Matsuura, Y Morishima, K Tajima, K Okochi, Y Hinuma.   

Abstract

A nation-wide survey of carriers of adult T-cell leukemia virus (ATLV) detected as anti-ATLA (ATLV-associated antigens) in volunteer blood donors was made in Japan. A total of 200 sera from donors between 40 and 64 years of age, collected in each of 64 blood centers located in eight districts, were tested for anti-ATLA by an indirect immunofluorescence test. The highest rate (8%) of seropositive donors was found in Kyushu and lower rates of 0.3 to 1.2% in other districts. However, the positive rate varied considerably in different localities even within districts with a high or low seropositive incidence. Further studies of all the donors (16 to 64 years old) in eight centers in Kyushu demonstrated two facts: (1) that the frequency of seropositive donors increased with age, and (2) that four centers in this district showed distinctly high incidences of seropositive donors, while the other four centers showed low incidences. The seropositive rate among all donors was estimated to be about 3% in Kyushu and 0.08 to 0.3% in all other districts.

Entities:  

Mesh:

Year:  1984        PMID: 6329964     DOI: 10.1002/ijc.2910330602

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

Review 1.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

Review 2.  Safety of blood transfusion: the Japanese experience.

Authors:  H Ikeda
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

3.  Prevalence of Human T Cell Leukaemia Virus amongst Blood Donors.

Authors:  C N Chaudhari; T Shah; R N Misra
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Anti HTLV-I antibodies and HLA phenotypes in the West Indies.

Authors:  M Chavance; N Monplaisir; I Valette; L Schaffar-Deshayes; C Raffoux
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

5.  Evaluation of passive particle agglutination test for antibody to human immunodeficiency virus.

Authors:  T Yoshida; T Matsui; S Kobayashi; N Yamamoto
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 6.  Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).

Authors:  K Tajima
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

7.  Prevalence of HTLV-I-associated uveitis in the Kanto Plain, Japan.

Authors:  M Ishioka; K Goto; S Nakamura; N Watanabe; E Uchio; K Saeki; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-08       Impact factor: 3.117

8.  Antibodies to ATLV/HTLV-1 in Africa.

Authors:  G Hunsmann; H Bayer; J Schneider; H Schmitz; P Kern; M Dietrich; D W Büttner; A M Goudeau; G Kulkarni; A F Fleming
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

9.  Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.

Authors:  Ayse Kubra Coskun; Richard E Sutton
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

10.  Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea.

Authors:  M P Sherman; N K Saksena; D K Dube; R Yanagihara; B J Poiesz
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.